Revenues from operations surged 327.50 per cent year-on-year (YoY) to Rs 12,855.30 crore compared with Rs 3,006.90 crore in the year-ago quarter. Total income of Rs 13,018.80 crore for the quarter was the highest ever, the company said.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.